Mesenchymal Stem Cells-Derived Exosomes: Next-Generation Nanomedicines Toward Scarless Wound Healing
International Journal of Nanomedicine · 2026
DOI: 10.2147/ijn.s586955 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Xiaohui Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing, 402260, People's Republic of China. Hauptthemen laut MEDLINE: Exosomes, Wound Healing, Mesenchymal Stem Cells, Cicatrix. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing, 402260, People's Republic of China.
- Key Laboratory of Optoelectronic Technology & Systems (Ministry of Education), Chongqing University, Chongqing, 400044, People's Republic of China.
- State Key Laboratory of New Textile Materials and Advanced Processing, Wuhan Textile University, Wuhan, Hubei, 430200, People's Republic of China.
ORCID-Profile: Debing Xiang
Zitieren
APA
Wang, X., Xu, Z., Lv, Y., & Xiang, D. (2026). Mesenchymal Stem Cells-Derived Exosomes: Next-Generation Nanomedicines Toward Scarless Wound Healing. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s586955
Vancouver
Wang X, Xu Z, Lv Y, Xiang D. Mesenchymal Stem Cells-Derived Exosomes: Next-Generation Nanomedicines Toward Scarless Wound Healing. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s586955
BibTeX
@article{Wang2026,
author = {Wang, Xiaohui and Xu, Zhiyuan and Lv, Yonggang and Xiang, Debing},
title = {Mesenchymal Stem Cells-Derived Exosomes: Next-Generation Nanomedicines Toward Scarless Wound Healing},
journal = {International Journal of Nanomedicine},
year = {2026},
doi = {10.2147/ijn.s586955}
}
EUVIMED